Sandra L. Dabora

3.6k total citations · 1 hit paper
28 papers, 2.7k citations indexed

About

Sandra L. Dabora is a scholar working on Physiology, Molecular Biology and Oncology. According to data from OpenAlex, Sandra L. Dabora has authored 28 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Physiology, 12 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in Sandra L. Dabora's work include Tuberous Sclerosis Complex Research (20 papers), Renal cell carcinoma treatment (7 papers) and Polyomavirus and related diseases (6 papers). Sandra L. Dabora is often cited by papers focused on Tuberous Sclerosis Complex Research (20 papers), Renal cell carcinoma treatment (7 papers) and Polyomavirus and related diseases (6 papers). Sandra L. Dabora collaborates with scholars based in United States, Poland and Sweden. Sandra L. Dabora's co-authors include David J. Kwiatkowski, David Neal Franz, Penelope Roberts, Sergiusz Jóźwiak, Elizabeth A. Thiele, Dorota Domańska‐Pakieła, Jolanta Kasprzyk‐Obara, Mary Pat Reeve, Andrés Nieto and Joon Yong Chung and has published in prestigious journals such as Cell, Journal of Clinical Investigation and Nature Neuroscience.

In The Last Decade

Sandra L. Dabora

28 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mutational Analysis in a Cohort of 224 Tuberous Sclerosis Patients Indicates Increased Severity of TSC2, Compared with TSC1, Disease in Multiple Organs

2001 700 citations Sandra L. Dabora, Sergiusz Jóźwiak et al. The American Journal of Human Genetics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sandra L. Dabora United States	18	1.6k	1.2k	695	541	388	28	2.7k
Jeffrey E. DeClue United States	29	878 0.6×	1.6k 1.3×	528 0.8×	381 0.7×	428 1.1×	43	2.9k
Hiroaki Onda United States	22	1.3k 0.8×	2.2k 1.8×	581 0.8×	252 0.5×	338 0.9×	36	3.4k
Mark Nellist Netherlands	31	2.1k 1.3×	1.4k 1.1×	871 1.3×	303 0.6×	223 0.6×	72	3.3k
Aristotelis Astrinidis United States	19	1.4k 0.9×	820 0.7×	618 0.9×	418 0.8×	132 0.3×	34	2.0k
Roberta L. Beauchamp United States	24	231 0.1×	657 0.5×	575 0.8×	308 0.6×	223 0.6×	41	1.8k
Jacqueline J.L. Jacobs Netherlands	24	814 0.5×	4.2k 3.4×	1.5k 2.1×	194 0.4×	321 0.8×	41	5.0k
Philippe Gascard United States	27	675 0.4×	1.4k 1.1×	575 0.8×	360 0.7×	542 1.4×	57	2.4k
Mary Pat Reeve United States	8	907 0.6×	859 0.7×	337 0.5×	154 0.3×	147 0.4×	17	1.8k
Tatyana V. Taksir United States	17	441 0.3×	1.0k 0.8×	336 0.5×	90 0.2×	164 0.4×	24	1.9k
John G. Conboy United States	38	1.4k 0.9×	2.7k 2.2×	103 0.1×	603 1.1×	808 2.1×	73	3.9k

Countries citing papers authored by Sandra L. Dabora

Since Specialization

Citations

This map shows the geographic impact of Sandra L. Dabora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra L. Dabora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra L. Dabora more than expected).

Fields of papers citing papers by Sandra L. Dabora

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra L. Dabora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra L. Dabora. The network helps show where Sandra L. Dabora may publish in the future.

Co-authorship network of co-authors of Sandra L. Dabora

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra L. Dabora. A scholar is included among the top collaborators of Sandra L. Dabora based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra L. Dabora. Sandra L. Dabora is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Malinowska, Izabela A., Nancy Y. Lee, Elizabeth A. Thiele, et al.. (2013). Similar Trends in Serum VEGF-D Levels and Kidney Angiomyolipoma Responses with Longer Duration Sirolimus Treatment in Adults with Tuberous Sclerosis. PLoS ONE. 8(2). e56199–e56199. 14 indexed citations

Dabora, Sandra L., David Neal Franz, Stephen Ashwal, et al.. (2011). Multicenter Phase 2 Trial of Sirolimus for Tuberous Sclerosis: Kidney Angiomyolipomas and Other Tumors Regress and VEGF- D Levels Decrease. PLoS ONE. 6(9). e23379–e23379. 159 indexed citations

Nie, Duyu, Alessia Di Nardo, Juliette M. Han, et al.. (2010). Tsc2-Rheb signaling regulates EphA-mediated axon guidance. Nature Neuroscience. 13(2). 163–172. 196 indexed citations

Dabora, Sandra L., et al.. (2010). Comparison of three rapamycin dosing schedules in A/J Tsc2+/- mice and improved survival with angiogenesis inhibitor or asparaginase treatment in mice with subcutaneous tuberous sclerosis related tumors. Journal of Translational Medicine. 8(1). 14–14. 31 indexed citations

Lee, Nancy Y., et al.. (2008). Topical rapamycin inhibits tuberous sclerosis tumor growth in a nude mouse model. BMC Dermatology. 8(1). 1–1. 33 indexed citations

Kozłowski, Piotr, Penelope Roberts, Sandra L. Dabora, et al.. (2007). Identification of 54 large deletions/duplications in TSC1 and TSC2 using MLPA, and genotype-phenotype correlations. Human Genetics. 121(3-4). 389–400. 134 indexed citations

Cho, Daniel, Sabina Signoretti, Sandra L. Dabora, et al.. (2007). Potential Histologic and Molecular Predictors of Response to Temsirolimus in Patients with Advanced Renal Cell Carcinoma. Clinical Genitourinary Cancer. 5(6). 379–385. 137 indexed citations

Borkowska, Julita, Dorota Domańska‐Pakieła, Jolanta Kasprzyk‐Obara, et al.. (2006). Clinical characteristics of tuberous sclerosis complex in patients with no TSC1 or TSC2 mutations identified. 15(30). 15–20. 1 indexed citations

Dabora, Sandra L., et al.. (2006). Combination of a rapamycin analog (CCI‐779) and interferon‐γ is more effective than single agents in treating a mouse model of tuberous sclerosis complex. Genes Chromosomes and Cancer. 45(10). 933–944. 34 indexed citations

10.

Walker, Victoria, Yanping Sun, Karl Schmidt, et al.. (2004). Efficacy of a rapamycin analog (CCI‐779) and IFN‐γ in tuberous sclerosis mouse models. Genes Chromosomes and Cancer. 42(3). 213–227. 132 indexed citations

11.

Roberts, Penelope, Vijaya Ramesh, Sandra L. Dabora, & David J. Kwiatkowski. (2003). A 34 bp Deletion WithinTSC2is a Rare Polymorphism, not a Pathogenic Mutation. Annals of Human Genetics. 67(6). 495–503. 7 indexed citations

12.

Roberts, Penelope, Joon Yong Chung, Sergiusz Jóźwiak, et al.. (2002). SNP identification, haplotype analysis, and parental origin of mutations in TSC2. Human Genetics. 111(1). 96–101. 9 indexed citations

13.

Dabora, Sandra L., Penelope Roberts, Andrés Nieto, et al.. (2002). Association between a High-Expressing Interferon-γ Allele and a Lower Frequency of Kidney Angiomyolipomas in TSC2 Patients. The American Journal of Human Genetics. 71(4). 750–758. 35 indexed citations

14.

Franz, David Neal, Alan S. Brody, Cristopher A. Meyer, et al.. (2001). Mutational and Radiographic Analysis of Pulmonary Disease Consistent with Lymphangioleiomyomatosis and Micronodular Pneumocyte Hyperplasia in Women with Tuberous Sclerosis. American Journal of Respiratory and Critical Care Medicine. 164(4). 661–668. 200 indexed citations

15.

Dabora, Sandra L., Sergiusz Jóźwiak, David Neal Franz, et al.. (2001). Mutational Analysis in a Cohort of 224 Tuberous Sclerosis Patients Indicates Increased Severity of TSC2, Compared with TSC1, Disease in Multiple Organs. The American Journal of Human Genetics. 68(1). 64–80. 700 indexed citations breakdown →

16.

Roberts, Penelope, Sergiusz Jóźwiak, David J. Kwiatkowski, & Sandra L. Dabora. (2001). Denaturing high-performance liquid chromatography (DHPLC) is a highly sensitive, semi-automated method for identifying mutations in the TSC1 gene. Journal of Biochemical and Biophysical Methods. 47(1-2). 33–37. 23 indexed citations

17.

Dabora, Sandra L., F. Scott Hall, Vijaya Ramesh, et al.. (1999). Superiority of Denaturing High Performance Liquid Chromatography over single‐stranded conformation and conformation‐sensitive gel electrophoresis for mutation detection in TSC2. Annals of Human Genetics. 63(5). 383–391. 92 indexed citations

18.

Dabora, Sandra L., et al.. (1998). Comprehensive mutation analysis of TSC1 using two‐dimensional DNA electrophoresis with DGGE. Annals of Human Genetics. 62(6). 491–504. 16 indexed citations

19.

Lamb, C A, et al.. (1993). Chapter 16 Microtubule Motor-Dependent Formation of Tubulovesicular Networks from Endoplasmic Reticulum and Golgi Membranes. Methods in cell biology. 39. 227–236. 5 indexed citations

20.

Dabora, Sandra L. & Michael P. Sheetz. (1988). Cultured cell extracts support organelle movement on microtubules in vitro. Cell Motility and the Cytoskeleton. 10(4). 482–495. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact